Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
Review

SGLT-2 inhibitors in heart failure and chronic kidney disease: A review for internists

Rahul Jaswaney, MD, Samantha Sokoloff, MD, Val Rakita, MD and Daniel J. Rubin, MD, MSc
Cleveland Clinic Journal of Medicine July 2024, 91 (7) 415-423; DOI: https://doi.org/10.3949/ccjm.91a.23093
Rahul Jaswaney
Fellow, Section of Cardiology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samantha Sokoloff
Fellow, Section of Endocrinology, Diabetes and Metabolism, Lewis Katz School of Medicine at Temple University, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Val Rakita
Associate Professor of Medicine; Associate Medical Director, Mechanical Circulatory Support Program; Director, CardioMEMS Program, Advanced Heart Failure, MCS, and Transplant Cardiology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel J. Rubin
Professor of Medicine, Interim Co-Director for the Center for Biostatistics and Epidemiology, Director of Clinical Research, and Deputy Chief, Section of Endocrinology, Diabetes and Metabolism, Lewis Katz School of Medicine at Temple University, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 91 no. 7 415-423
DOI 
https://doi.org/10.3949/ccjm.91a.23093
PubMed 
38950981

Published By 
Cleveland Clinic Journal of Medicine
Print ISSN 
0891-1150
Online ISSN 
1939-2869
History 
  • Published online July 1, 2024.

Copyright & Usage 
Copyright © 2024 The Cleveland Clinic Foundation. All Rights Reserved.

Author Information

  1. Rahul Jaswaney, MD
  1. Fellow, Section of Cardiology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA
  1. Samantha Sokoloff, MD
  1. Fellow, Section of Endocrinology, Diabetes and Metabolism, Lewis Katz School of Medicine at Temple University, Philadelphia, PA
  1. Val Rakita, MD
  1. Associate Professor of Medicine; Associate Medical Director, Mechanical Circulatory Support Program; Director, CardioMEMS Program, Advanced Heart Failure, MCS, and Transplant Cardiology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA
  1. Daniel J. Rubin, MD, MSc⇑
  1. Professor of Medicine, Interim Co-Director for the Center for Biostatistics and Epidemiology, Director of Clinical Research, and Deputy Chief, Section of Endocrinology, Diabetes and Metabolism, Lewis Katz School of Medicine at Temple University, Philadelphia, PA
  1. Address:
    Daniel J. Rubin, MD, MSc, Lewis Katz School of Medicine at Temple University, Medical Office Building 3322 N. Broad Street, Suite 205, Philadelphia, PA 19140; Daniel.rubin{at}tuhs.temple.edu
View Abstract

Cited By...

  • 4 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 91 (7)
Cleveland Clinic Journal of Medicine
Vol. 91, Issue 7
1 Jul 2024
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
SGLT-2 inhibitors in heart failure and chronic kidney disease: A review for internists
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
SGLT-2 inhibitors in heart failure and chronic kidney disease: A review for internists
Rahul Jaswaney, Samantha Sokoloff, Val Rakita, Daniel J. Rubin
Cleveland Clinic Journal of Medicine Jul 2024, 91 (7) 415-423; DOI: 10.3949/ccjm.91a.23093

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
SGLT-2 inhibitors in heart failure and chronic kidney disease: A review for internists
Rahul Jaswaney, Samantha Sokoloff, Val Rakita, Daniel J. Rubin
Cleveland Clinic Journal of Medicine Jul 2024, 91 (7) 415-423; DOI: 10.3949/ccjm.91a.23093
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • ABSTRACT
    • SGLT-2 INHIBITORS IN HEART FAILURE
    • SGLT-2 INHIBITORS AND CHRONIC KIDNEY DISEASE
    • PRACTICAL PRESCRIBING CONSIDERATIONS
    • CONCLUSION
    • DISCLOSURES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • SGLT-2 inhibitors: Diabetes and CKD and CHF (and gout?), oh my!
  • Google Scholar

More in this TOC Section

  • Managing right ventricular failure in the setting of pulmonary embolism
  • Alpha-gal syndrome: Recognizing and managing a tick-bite–related meat allergy
  • Psychedelics, spirituality, and existential distress in patients at the end of life
Show more Review

Similar Articles

Subjects

  • Cardiology
  • Diabetes
  • Nephrology

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire